Søgning på udtrykket 'influenza' giver 45 resultater
Dokumenter [1] Sider [2] Kalender [2] Nyt fra tidsskrifterne [+20] Aktuelle smitsomme sygdomme [+20]
Dokumenter [1]
Væsentlige ændringer siden sidste version (fra 2013): 1) Anbefaling af at alle patienter, der tilhører de af SST definerede risikogrupper, med nyopstået influenza (indenfor de to første døgn) under et udbrud behandles med oseltamivir for at reducere risiko for efterfølgende kompliceret influenza. En opgave som især primær praksis og ambulatorier med sådanne patienter i langvarige forløb skal være opmærksom på. 2) Revision af håndtering af influenza sygdom på lokalisationer med adgang til…
Sider [2]
…ektionsmedicin i Den Fælles Akutte Modtagelse (FAM): Hanne Arildsen, Susanna Deutch, Suzanne Lunding, Purnima Erichsen, Rikke Krogh-Madsen, Toke Barfod, Ulla Balslev, Lotte Ebdrup, Lars Toft Nielsen, Jon Holler For yderligere info, klik her Influenza: Gitte Kronborg, Jens Lundgren, Ulrik Dragsted, Jan Gerstoft, Henrik Nielsen Influenza, Inspektorordningen i Sundhedsstyrelsen: Hanne Arildsen, Thomas Benfield Kronisk viral hepatitis: Nina Weis, Peer B Christensen…
…ogle forskellige kilder til viden. EBJIS. European Bone and Joint Infection Society (EBJIS) udbyder flere gratis webinarer om knogleinfektioner. ebjis.org/e-events/on-demand-webinars. FluNet. WHO's overvågning af influenza:. www.who.int/flunet. HAIBA. Healthcare-Associated Infections Database (HAIBA) er et nationalt automatisk overvågningssystem til overvågning af infektioner erhvervet i sundhedssektoren. www.esundhed.dk/Emner/…
Kalender [2]
24. januar 2019, Aarhus Universitetshospital
9. november 2018, Korsør
Nyt fra tidsskrifterne [+20]
Der er mere end 20 resultater, måske du vil se flere resultater her?International Journal of Infectious Diseases
15.05.2022
: Due to the spread of the Omicron variant, many countries have experienced COVID-19 case numbers unseen since the start of the pandemic. We aimed to compare the epidemiological characteristics of Omicron with prior variants and different strains of influenza, to provide context for public health responses.
Journal of Medical Virology
13.05.2022
Journal of Medical Virology, Accepted Article.
Emerging Infectious Diseases
13.05.2022
V. Potdar et al.
Science Advances
11.05.2022
Science Advances, <a href='www.science.org/toc/sciadv/8/19'>Volume 8, Issue 19</a>, May 2022.
PLoS One Infectious Diseases
10.05.2022
by Cristalyne Bell, Maureen Goss, Jennifer Birstler, Emily Temte, Guanhua Chen, Peter Shult, Erik Reisdorf, Thomas Haupt, Shari Barlow, Jonathan Temte. Background Seasonal influenza leads to an increase in outpatient clinic visits. Timely, accurate, and affordable testing could facilitate improved treatment outcomes. Rapid influenza diagnostic tests (RIDTs) provide results in as little as 15 minutes and are relatively inexpensive, but have reduced sensitivity when compared to RT-PCR. The contributions of m…
PLoS One Infectious Diseases
9.05.2022
by Fatima Noor, Muhammad Hamzah Saleem, Muhammad Rizwan Javed, Jen-Tsung Chen, Usman Ali Ashfaq, Mohammad K. Okla, Mostafa A. Abdel-Maksoud, Yasmeen A. Alwasel, Wahidah H. Al-Qahtani, Huda Alshaya, Ghulam Yasin, Sidra Aslam. . H5N1 virus (H5N1V) is highly contagious among birds and it was first detected in humans in 1997 during a poultry outbreak in Hong Kong. As the mechanism of its pathogenesis inside the host is still lacking, in this in-silico study we hypothesized that H5N1V might create miRNAs, whic…
Journal of Medical Virology
9.05.2022
Journal of Medical Virology, Accepted Article.
Tropical Medicine & International Health
28.04.2022
Tropical Medicine & International Health, Accepted Article.
Journal of Medical Virology
28.04.2022
Journal of Medical Virology, Accepted Article.
Emerging Infectious Diseases
27.04.2022
W. Zhu et al.
International Journal of Infectious Diseases
24.04.2022
: Epidemiological characteristics profile of the reinfection of the influenza virus has not been well described.
Journal of Medical Virology
22.04.2022
Journal of Medical Virology, Accepted Article.
Lancet Infectious Diseases
22.04.2022
The development of next-generation influenza vaccines with increased breadth and duration of protection is among one of the objectives in WHO's Global Influenza Strategy for 2019–2030, which calls for the development of improved global tools by 2030 to benefit all countries and to instil public confidence and vaccine uptake.1 Over the past two decades, more than 100 universal influenza vaccine prototypes have been proposed; however, only few have progressed beyond animal studies, and even fewer results ha…
Lancet Infectious Diseases
22.04.2022
The stalk domain seems to be a rational target for development of a universal influenza virus vaccine via administration of chimeric haemagglutinins with head domains to which humans are naive.
PLoS One Infectious Diseases
19.04.2022
by Jonathan L. Temte, Shari Barlow, Maureen Goss, Emily Temte, Amber Schemmel, Cristalyne Bell, Erik Reisdorf, Peter Shult, Mary Wedig, Thomas Haupt, James H. Conway, Ronald Gangnon, Amra Uzicanin. Background Schools are primary venues of influenza amplification with secondary spread to communities. We assessed K-12 student absenteeism monitoring as a means for early detection of influenza activity in the community. Materials and methods Between September 2014 and March 2020, we conducted a prospective ob…
BMJ Open
18.04.2022
. Objective. To compare facility-level influenza vaccination rates in long-term care (LTC) homes from four countries and to identify factors associated with influenza vaccination among residents. . Design and setting. Retrospective cross-sectional study of individuals residing in LTC homes in New Brunswick (Canada), New Zealand, Switzerland, and the Netherlands between 2017 and 2020. . Participants. LTC home residents assessed with interRAI assessment system instruments as part of routine practice i…
PLoS One Infectious Diseases
18.04.2022
by Nour Abed Elhadi Shahbari, Anat Gesser-Edelsburg, Nadav Davidovitch, Shuli Brammli-Greenberg, Gustavo S. Mesch. Background The issue of whether to include seasonal influenza vaccinations in school-located vaccination programs (SLIV) has been examined in many countries, mainly in the context of economic effectiveness and morbidity prevention. Yet not enough studies have examined the impact of parental risk perceptions, health literacy and SLIV on parental vaccination uptake. Objectives The most recent s…
Infection and Immunity
18.04.2022
Infection and Immunity, Ahead of Print.
BMJ Open
15.04.2022
. Objectives. To characterise the quality of life, healthcare use and costs associated with early antibiotic treatment of influenza-like illness (ILI) in ‘at-risk’ children. . Design. Economic analysis of a two-arm double-blind parallel group pragmatic randomised controlled trial. . Setting. Children were recruited from community-based healthcare settings, including general practices, walk-in centres and hospital ambulatory care. . Participants. Children with risk factors for influenz…
Aktuelle smitsomme sygdomme [+20]
Der er mere end 20 resultater, måske du vil se flere resultater her?ProMED
13.05.2022
Avian Influenza H5N1 -- Canada
ProMED
12.05.2022
Avian Influenza H5N1 -- United States
ProMED
12.05.2022
Avian Influenza -- Bulgaria
ProMED
11.05.2022
Avian Influenza H5N1 -- United States
ProMED
9.05.2022
Avian Influenza H5N1 -- Canada
ProMED
9.05.2022
Avian Influenza -- United States
ProMED
7.05.2022
Avian Influenza H5N1 -- Iceland
ProMED
6.05.2022
Avian Influenza H5N1 -- Iceland
ProMED
6.05.2022
Equine Influenza -- United States
ProMED
5.05.2022
Avian Influenza H5N1 -- Canada
ProMED
3.05.2022
Avian Influenza H5N8 -- Israel
ProMED
3.05.2022
Avian Influenza H5N1 --
ProMED
30.04.2022
Avian Influenza -- China
ProMED
30.04.2022
Avian Influenza H5N1 --
ProMED
30.04.2022
Avian Influenza H5N1 -- Canada
ProMED
30.04.2022
Equine Influenza -- United States
ProMED
29.04.2022
Avian Influenza H5N1 -- United States
ProMED
29.04.2022
Avian Influenza H5N1 -- Canada
ProMED
29.04.2022
Avian Influenza -- Mexico
Statens Serum Institut
28.04.2022
Nu er kun 16% af de covid-19-testede der er positive og kun 9,6% af de, der testes for Influenza, måles positive. Det viser den nyeste tendensrapport fra Statens Serum Institut.